CU23475A1 - Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinas - Google Patents
Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinasInfo
- Publication number
- CU23475A1 CU23475A1 CU20040147A CU20040147A CU23475A1 CU 23475 A1 CU23475 A1 CU 23475A1 CU 20040147 A CU20040147 A CU 20040147A CU 20040147 A CU20040147 A CU 20040147A CU 23475 A1 CU23475 A1 CU 23475A1
- Authority
- CU
- Cuba
- Prior art keywords
- composition
- polypeptide fragments
- serralisine
- pharmaceutical composition
- tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/265—Enterobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención está relacionada con una composición capaz de inhibir el crecimiento de células tumorales de diferentes orígenes histológicos y de célulasendoteliales activadas. Lo scomponentes de dicha composición son fragmentos polipeptídicos de Serralisinas, correspondientes al fragmento C-terminal, a partir de la metionina interna de la secuencia hasta el final de la molécula los cuales pueden combinarse entre ellos y opcionalmente con prodigiosinas que potencian el efecto antitumoral de la composición. Las prodigiosinas en la composición pueden estar a ubna concentración de 0.1-100nM. La acción anti-proliferativa de la composición está mediada por mecanismos apoptóticos. Su administración " in vivo" tiene efecto anti-tumoral, antiangiogénico y protecdtor contra tumores malignos.
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20040147A CU23475A1 (es) | 2004-07-08 | 2004-07-08 | Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinas |
DK05762122.9T DK1787653T3 (da) | 2004-07-08 | 2005-07-05 | Antitumoral farmaceutisk sammensætning indeholdende polypeptidfragmenter af serralysiner |
SI200531578T SI1787653T1 (sl) | 2004-07-08 | 2005-07-05 | Protitumorski farmacevtski sestavek, ki vsebuje polipeptidne fragmente seralizinov |
PCT/CU2005/000003 WO2006005268A2 (es) | 2004-07-08 | 2005-07-05 | Composición farmacéutica conteniendo fragmentos polipéptidicos de serralisinas |
BRPI0513136-7A BRPI0513136A (pt) | 2004-07-08 | 2005-07-05 | composição farmacêutica contendo fragmentos de polipeptìdeo das serralisinas |
RU2007104776/13A RU2396274C2 (ru) | 2004-07-08 | 2005-07-05 | Противоопухолевая фармацевтическая композиция (варианты) и ее применение |
US11/631,880 US8076297B2 (en) | 2004-07-08 | 2005-07-05 | Pharmaceutical composition containing polypeptide fragments of serralysins |
EP05762122A EP1787653B1 (en) | 2004-07-08 | 2005-07-05 | Antitumoral pharmaceutical composition containing polypeptide fragments of serralysins |
AU2005262159A AU2005262159B2 (en) | 2004-07-08 | 2005-07-05 | Pharmaceutical composition containing polypeptide fragments of serralysins |
PT05762122T PT1787653E (pt) | 2004-07-08 | 2005-07-05 | Composição farmacêutica contendo fragmentos de polipéptidos de serralisinas |
PL05762122T PL1787653T3 (pl) | 2004-07-08 | 2005-07-05 | Przeciwnowotworowa kompozycja farmaceutyczna zawierająca fragmenty polipeptydowe serralizyn |
CA2572984A CA2572984C (en) | 2004-07-08 | 2005-07-05 | A pharmaceutical composition containing polypeptide fragments of the serralysins |
RS20120391A RS52448B (en) | 2004-07-08 | 2005-07-05 | ANTITUMOR PHARMACEUTICAL COMPOSITION CONTAINING SERALIZIN POLYPEPTIDE FRAGMENTS |
KR1020077002589A KR101365056B1 (ko) | 2004-07-08 | 2005-07-05 | 세라리신의 폴리펩티드 분획을 포함하는 약학적 조성물 |
ES05762122T ES2389126T3 (es) | 2004-07-08 | 2005-07-05 | Composición farmacéutica antitumoral que contiene fragmentos polipeptídicos de serralisinas |
JP2007519599A JP4914350B2 (ja) | 2004-07-08 | 2005-07-05 | セラリシン(Serralisins)のポリペプチド断片を含む医薬組成物 |
MX2007000339A MX2007000339A (es) | 2004-07-08 | 2005-07-05 | Composicion farmaceutica conteniendo fragmentos polipeptidicos de serralisinas. |
MYPI20053102 MY150858A (en) | 2004-07-08 | 2005-07-07 | A pharmaceutical composition containing polypeptide fragments of the serralysins |
ARP050102834A AR050255A1 (es) | 2004-07-08 | 2005-07-08 | Composicion farmaceutica conteniendo fragmentos polipeptidicos de serralisinas |
ZA200700178A ZA200700178B (en) | 2004-07-08 | 2007-01-05 | Pharmaceutical composition containing polypeptide fragments of serralysins |
HRP20120682TT HRP20120682T1 (hr) | 2004-07-08 | 2012-08-27 | Protutumorski farmaceutski sastav koji sadr“i polipeptidne fragmente od seralizina |
CY20121100800T CY1114201T1 (el) | 2004-07-08 | 2012-09-05 | Αντιογκογονικη φαρμακευτικη συνθεση που περιεχει θραυσματα πολυπεπτιδιων σερραλυσινων |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20040147A CU23475A1 (es) | 2004-07-08 | 2004-07-08 | Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinas |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23475A1 true CU23475A1 (es) | 2009-12-17 |
Family
ID=40259088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20040147A CU23475A1 (es) | 2004-07-08 | 2004-07-08 | Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinas |
Country Status (22)
Country | Link |
---|---|
US (1) | US8076297B2 (es) |
EP (1) | EP1787653B1 (es) |
JP (1) | JP4914350B2 (es) |
KR (1) | KR101365056B1 (es) |
AR (1) | AR050255A1 (es) |
AU (1) | AU2005262159B2 (es) |
BR (1) | BRPI0513136A (es) |
CA (1) | CA2572984C (es) |
CU (1) | CU23475A1 (es) |
CY (1) | CY1114201T1 (es) |
DK (1) | DK1787653T3 (es) |
ES (1) | ES2389126T3 (es) |
HR (1) | HRP20120682T1 (es) |
MX (1) | MX2007000339A (es) |
MY (1) | MY150858A (es) |
PL (1) | PL1787653T3 (es) |
PT (1) | PT1787653E (es) |
RS (1) | RS52448B (es) |
RU (1) | RU2396274C2 (es) |
SI (1) | SI1787653T1 (es) |
WO (1) | WO2006005268A2 (es) |
ZA (1) | ZA200700178B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2587139C (en) * | 2004-11-23 | 2014-05-27 | Zymogenetics, Inc. | Purification of recombinant human factor xiii |
JP5296051B2 (ja) | 2007-05-04 | 2013-09-25 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Mrコイル吸収の補正を伴うハイブリッドmr/pet |
CU23950B1 (es) * | 2011-03-21 | 2013-10-29 | Ct De Ingeniería Genética Y Biotecnología | Péptidos cíclicos con actividad antineoplásica y antiangiogénica |
TWI746449B (zh) * | 2015-07-20 | 2021-11-21 | 美商Ai治療公司 | 使用阿吡莫德治療癌症之方法 |
CN109295041A (zh) * | 2018-10-10 | 2019-02-01 | 宁波希诺亚海洋生物科技有限公司 | 具有舍雷肽酶活性的多肽及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58134991A (ja) * | 1981-12-28 | 1983-08-11 | Takeda Chem Ind Ltd | セラチオペプチタ−ゼの安定化法 |
JP2611206B2 (ja) * | 1985-11-15 | 1997-05-21 | 武田薬品工業株式会社 | 遺伝子およびその利用方法 |
KR100252197B1 (ko) | 1997-09-20 | 2000-04-15 | 박호군 | 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신 |
US20040185566A1 (en) * | 2003-03-19 | 2004-09-23 | Peter Salamone | Polypeptides toxic to nematodes and methods of use |
-
2004
- 2004-07-08 CU CU20040147A patent/CU23475A1/es unknown
-
2005
- 2005-07-05 PL PL05762122T patent/PL1787653T3/pl unknown
- 2005-07-05 PT PT05762122T patent/PT1787653E/pt unknown
- 2005-07-05 RU RU2007104776/13A patent/RU2396274C2/ru not_active IP Right Cessation
- 2005-07-05 DK DK05762122.9T patent/DK1787653T3/da active
- 2005-07-05 EP EP05762122A patent/EP1787653B1/en active Active
- 2005-07-05 RS RS20120391A patent/RS52448B/en unknown
- 2005-07-05 MX MX2007000339A patent/MX2007000339A/es active IP Right Grant
- 2005-07-05 US US11/631,880 patent/US8076297B2/en not_active Expired - Fee Related
- 2005-07-05 WO PCT/CU2005/000003 patent/WO2006005268A2/es active Search and Examination
- 2005-07-05 SI SI200531578T patent/SI1787653T1/sl unknown
- 2005-07-05 BR BRPI0513136-7A patent/BRPI0513136A/pt not_active Application Discontinuation
- 2005-07-05 CA CA2572984A patent/CA2572984C/en not_active Expired - Fee Related
- 2005-07-05 JP JP2007519599A patent/JP4914350B2/ja not_active Expired - Fee Related
- 2005-07-05 AU AU2005262159A patent/AU2005262159B2/en not_active Ceased
- 2005-07-05 KR KR1020077002589A patent/KR101365056B1/ko active IP Right Grant
- 2005-07-05 ES ES05762122T patent/ES2389126T3/es active Active
- 2005-07-07 MY MYPI20053102 patent/MY150858A/en unknown
- 2005-07-08 AR ARP050102834A patent/AR050255A1/es active IP Right Grant
-
2007
- 2007-01-05 ZA ZA200700178A patent/ZA200700178B/xx unknown
-
2012
- 2012-08-27 HR HRP20120682TT patent/HRP20120682T1/hr unknown
- 2012-09-05 CY CY20121100800T patent/CY1114201T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005262159A1 (en) | 2006-01-19 |
ES2389126T3 (es) | 2012-10-23 |
KR101365056B1 (ko) | 2014-02-21 |
MX2007000339A (es) | 2007-03-12 |
RU2007104776A (ru) | 2008-08-20 |
EP1787653B1 (en) | 2012-06-06 |
AR050255A1 (es) | 2006-10-11 |
EP1787653A2 (en) | 2007-05-23 |
AU2005262159B2 (en) | 2011-08-18 |
RU2396274C2 (ru) | 2010-08-10 |
CY1114201T1 (el) | 2016-08-31 |
PT1787653E (pt) | 2012-09-06 |
CA2572984C (en) | 2014-12-09 |
US8076297B2 (en) | 2011-12-13 |
BRPI0513136A (pt) | 2008-04-29 |
ZA200700178B (en) | 2008-06-25 |
KR20070042542A (ko) | 2007-04-23 |
CA2572984A1 (en) | 2006-01-19 |
US20110218138A1 (en) | 2011-09-08 |
WO2006005268A3 (es) | 2006-03-09 |
HRP20120682T1 (hr) | 2012-09-30 |
PL1787653T3 (pl) | 2012-11-30 |
WO2006005268A2 (es) | 2006-01-19 |
SI1787653T1 (sl) | 2012-10-30 |
MY150858A (en) | 2014-03-14 |
RS52448B (en) | 2013-02-28 |
DK1787653T3 (da) | 2012-09-17 |
JP2008505129A (ja) | 2008-02-21 |
JP4914350B2 (ja) | 2012-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0316050A (pt) | Métodos de tratar, controlar ou prevenir um câncer especìfico e doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com terapia de radiação, terapia hormonal, terapia biológica, ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit | |
ATE535252T1 (de) | Peptid-konjugat-zusammensetzungen und -verfahren zur prävention und behandlung von alzheimer- krankheit | |
EP3533461A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
HK1101131A1 (en) | Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients | |
AR094178A1 (es) | Derivados de exendina-4 funcionalizada | |
BRPI0607326B8 (pt) | composição de vacina, uso da referida composição e kit em partes | |
AR053651A1 (es) | Tratamiento combinado de anticuerpo antictla4 r inhibidor de aromatasa para el cancer de mama | |
PE20121393A1 (es) | Analogo peptidico de oxintomodulina | |
BRPI0816784A8 (pt) | Fatores neuro-endócrinos para o tratamento de doenças degenerativas | |
AR054526A1 (es) | Metodo para tartar pacientes con una vacuna de glicoproteina mucinosa (muc-1) | |
CU23792A3 (es) | Novedosos anticuerpos antiproliferación | |
AR050255A1 (es) | Composicion farmaceutica conteniendo fragmentos polipeptidicos de serralisinas | |
CO6400198A2 (es) | Composiciones y metodos novedosos | |
BR112014024358A2 (pt) | uso de iduronate-2-sulfatase por via subcutânea e kit | |
DE602004014145D1 (de) | Von rasgap-abgeleitetes peptid zur gezielten tötung von krebszellen | |
AR057565A1 (es) | Interferon alfa y c- ficocianina para el tratamiento de enfermedades auoinmunes alergicas y cancer | |
ATE494301T1 (de) | Alpha-fetoprotein-peptide und ihre verwendung | |
UY32600A (es) | Formulación en lípidos de un promotor de la apoptosis | |
RU2016135003A (ru) | Новые виды лечения | |
ATE458819T1 (de) | Konjugat mit p21-protein zur krebsbehandlung | |
WO2010023195A3 (en) | Compositions and methods for treating cancer | |
ATE484290T1 (de) | Peptid mit antitumoraler wirkung | |
ATE552271T1 (de) | Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon | |
EA200700413A1 (ru) | Ариламинкетоны, способ их получения, фармацевтические композиции, содержащие их, и их применение | |
AR073585A1 (es) | Una proteina rica en cisteina derivada de suero en pacientes que reciben quimioterapia o radioterapia para mejorar la supervivencia de dichos pacientes. uso. metodo |